4000 IU Recombinant Human Erythropoietin Injection

Get a Price/Quote

MOQ : 100 Packs

4000 IU Recombinant Human Erythropoietin Injection Specification

Indication
Anemia associated with chronic renal failure, cancer chemotherapy, HIV infection, and surgery

Salt Composition
Recombinant Human Erythropoietin 4000 IU

Dosage Form
Injection

Enzyme Types
Glycoprotein hormone, Erythropoiesis-stimulating agent (ESA)

Feature
Sterile, pyrogen-free, ready-to-use, single-dose vial

Ingredients
Active: Recombinant Human Erythropoietin; Excipients: solvents, stabilizers, carriers

Application
Promotes erythropoiesis to increase red blood cell production

Ph Level
Approximately 6.5 - 7.5

Temperature Needed For Fermentation
36C to 37C

Physical Color/Texture
Clear to slightly opalescent, colorless liquid

Fermentation Smell
Odorless

Enzymatic Activity
Stimulates formation of erythrocytes by the bone marrow

Storage Instructions
Store at 2C to 8C, do not freeze, protect from light

Shelf Life
24 months from manufacturing date

Packaging Type
Single-use vial, typically with outer carton

Contraindication
Uncontrolled hypertension, hypersensitivity to components

Strength
4000 IU per 1 ml vial

Export Market
Available for domestic and international markets

Compatibility
Do not mix with other drugs in the same syringe

NDC/HSN Code
As per regulatory requirement

Brand Name
Varies (refer to manufacturer's specific brand)

Route of Administration
Intravenous or subcutaneous

Patient Population
Adults and children as prescribed

Preservative Free
Yes

4000 IU Recombinant Human Erythropoietin Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About 4000 IU Recombinant Human Erythropoietin Injection

Access preeminent care with 4000 IU Recombinant Human Erythropoietin Injection-an astounding solution trusted by top-rated healthcare professionals. This magnificent erythropoiesis-stimulating agent (ESA) promotes red blood cell production in adults and children prescribed for anemia due to chronic renal failure, cancer, HIV, or surgery. Packaged in a sterile, single-use vial and preservative-free, it is administered intravenously or subcutaneously for optimal efficacy. Shop now for this rigorously quality-assured product, compliant with regulatory NDC/HSN codes, available for both domestic and international markets from leading suppliers and traders across India.

Material Features, Advantage & Application Site

The 4000 IU Recombinant Human Erythropoietin Injection is a sterile, pyrogen-free, and preservative-free formulation, ensuring safety and purity for patients. Its chief advantage lies in its targeted stimulation of bone marrow to increase erythrocyte formation, supporting improved oxygen transport in the body. Ready-to-use in a single-dose vial, this clear, colorless solution is intended for intravenous or subcutaneous administration at medical facilities, providing flexibility in clinical and home settings alike.

Export Markets, Delivery Timelines & Domestic Reach

This injection serves both domestic and international markets, providing global healthcare providers access to a clinically trusted, high-quality product at the lowest price. Our streamlined goods transport system accelerates delivery, ensuring timely and secure receipt of products. Competitive proposal amounts are tailored for diverse healthcare requirements, supporting clients in India and abroad. The commitment to efficiency and service reliability fortifies our position as a preferred supplier and trader in the pharmaceutical sector.

FAQ's of 4000 IU Recombinant Human Erythropoietin Injection:

Q: How should the 4000 IU Recombinant Human Erythropoietin Injection be administered?

A: This injection is designed for intravenous or subcutaneous administration, as directed by a healthcare professional. It should not be mixed with other drugs in the same syringe.

Q: What are the primary medical indications for this injection?

A: The injection is indicated for the treatment of anemia associated with chronic renal failure, cancer therapy, HIV infection, and surgical procedures, as determined by a physician.

Q: When should this product not be used?

A: It is contraindicated in patients with uncontrolled hypertension or hypersensitivity to any of its components. Consult your doctor before starting this therapy.

Q: Where should the injection be stored for optimal potency?

A: Store the injection in a refrigerator at 2C to 8C, protected from light. Do not freeze the solution.

Q: What benefits does the recombinant formulation offer?

A: Being a glycoprotein hormone, the recombinant formulation precisely mimics natural erythropoietin, efficiently stimulating red blood cell production and improving anemia outcomes with minimal immunogenic risk.